Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders Equity

v3.24.3
Condensed Consolidated Statements of Stockholders Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Common stock, beginning balance (in shares) at Dec. 31, 2022   622,602,815      
Beginning balance at Dec. 31, 2022 $ 1,164,741 $ 61 $ 1,908,179 $ (734,653) $ (8,846)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (113,393)     (113,393)  
Stock-based compensation 14,157   14,157    
Issuance of common stock upon exercise of stock options (in shares)   945,803      
Issuance of common stock upon exercise of stock options 614   614    
Issuance of common stock upon the release of restricted stock units (in shares)   5,836,813      
Vesting of early exercised stock options 104   104    
Issuance of common stock in private placement (in shares)   137,174      
Other comprehensive (loss) income 3,272       3,272
Common stock, ending balance (in shares) at Mar. 31, 2023   629,522,605      
Ending balance at Mar. 31, 2023 1,069,495 $ 61 1,923,054 (848,046) (5,574)
Common stock, beginning balance (in shares) at Dec. 31, 2022   622,602,815      
Beginning balance at Dec. 31, 2022 1,164,741 $ 61 1,908,179 (734,653) (8,846)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (397,947)        
Common stock, ending balance (in shares) at Sep. 30, 2023   694,692,591      
Ending balance at Sep. 30, 2023 1,109,334 $ 69 2,244,617 (1,132,600) (2,752)
Common stock, beginning balance (in shares) at Mar. 31, 2023   629,522,605      
Beginning balance at Mar. 31, 2023 1,069,495 $ 61 1,923,054 (848,046) (5,574)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (286,079)     (286,079)  
Stock-based compensation 15,232   15,232    
Issuance of common stock upon exercise of stock options (in shares)   914,077      
Issuance of common stock upon exercise of stock options 679   679    
Issuance of common stock upon the release of restricted stock units (in shares)   2,053,991      
Issuance of common stock under the Employee Stock Purchase Plan (in shares)   1,047,001      
Issuance of common stock under the Employee Stock Purchase Plan 3,801   3,801    
Vesting of early exercised stock options 93   93    
Issuance of common stock in private placement (in shares)   59,023,275      
Issuance of common stock in private placement 280,196 $ 6 280,190    
Other comprehensive (loss) income 1,135       1,135
Common stock, ending balance (in shares) at Jun. 30, 2023   692,560,949      
Ending balance at Jun. 30, 2023 1,084,552 $ 67 2,223,049 (1,134,125) (4,439)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 1,525     1,525  
Stock-based compensation 21,456   21,456    
Issuance of common stock upon exercise of stock options (in shares)   410,690      
Issuance of common stock upon exercise of stock options 278 $ 2 276    
Issuance of common stock upon the release of restricted stock units (in shares)   1,720,952      
Offering costs for issuance of common stock in private placement (298)   (298)    
Vesting of early exercised stock options 134   134    
Other comprehensive (loss) income 1,687       1,687
Common stock, ending balance (in shares) at Sep. 30, 2023   694,692,591      
Ending balance at Sep. 30, 2023 $ 1,109,334 $ 69 2,244,617 (1,132,600) (2,752)
Common stock, beginning balance (in shares) at Dec. 31, 2023 698,262,025 698,262,025      
Beginning balance at Dec. 31, 2023 $ 1,034,362 $ 70 2,282,475 (1,247,703) (480)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (94,587)     (94,587)  
Stock-based compensation 35,328   35,328    
Issuance of common stock upon exercise of stock options (in shares)   1,016,414      
Issuance of common stock upon exercise of stock options 943   943    
Issuance of common stock upon the release of restricted stock units (in shares)   6,034,056      
Vesting of early exercised stock options 186   186    
Other comprehensive (loss) income (1,101)       (1,101)
Common stock, ending balance (in shares) at Mar. 31, 2024   705,312,495      
Ending balance at Mar. 31, 2024 $ 975,131 $ 70 2,318,932 (1,342,290) (1,581)
Common stock, beginning balance (in shares) at Dec. 31, 2023 698,262,025 698,262,025      
Beginning balance at Dec. 31, 2023 $ 1,034,362 $ 70 2,282,475 (1,247,703) (480)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) $ (361,757)        
Common stock, ending balance (in shares) at Sep. 30, 2024 717,094,083 717,094,083      
Ending balance at Sep. 30, 2024 $ 781,039 $ 71 2,389,751 (1,609,460) 677
Common stock, beginning balance (in shares) at Mar. 31, 2024   705,312,495      
Beginning balance at Mar. 31, 2024 975,131 $ 70 2,318,932 (1,342,290) (1,581)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (123,292)     (123,292)  
Stock-based compensation 28,441   28,441    
Issuance of common stock upon exercise of stock options (in shares)   424,313      
Issuance of common stock upon exercise of stock options 312 $ 1 311    
Issuance of common stock upon the release of restricted stock units (in shares)   3,594,727      
Issuance of common stock under the Employee Stock Purchase Plan (in shares)   1,227,816      
Issuance of common stock under the Employee Stock Purchase Plan 4,942   4,942    
Issuance of common stock in acquisition (in shares)   3,320,235      
Issuance of common stock in acquisition 9,472   9,472    
Vesting of early exercised stock options 30   30    
Other comprehensive (loss) income (452)       (452)
Common stock, ending balance (in shares) at Jun. 30, 2024   713,879,586      
Ending balance at Jun. 30, 2024 894,584 $ 71 2,362,128 (1,465,582) (2,033)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (143,878)     (143,878)  
Stock-based compensation 27,391   27,391    
Issuance of common stock upon exercise of stock options (in shares)   1,015,276      
Issuance of common stock upon exercise of stock options 207   207    
Issuance of common stock upon the release of restricted stock units (in shares)   2,199,221      
Vesting of early exercised stock options 25   25    
Other comprehensive (loss) income $ 2,710       2,710
Common stock, ending balance (in shares) at Sep. 30, 2024 717,094,083 717,094,083      
Ending balance at Sep. 30, 2024 $ 781,039 $ 71 $ 2,389,751 $ (1,609,460) $ 677